Outcomes following poor-grade aneurysmal subarachnoid haemorrhage: a prospective observational study. 2023

Jack Henry, and Mohammed O Dablouk, and Dhruv Kapoor, and Stavros Koustais, and Paula Corr, and Deirdre Nolan, and Deirdre Coffey, and John Thornton, and Alan O'Hare, and Sarah Power, and Daniel Rawluk, and Mohsen Javadpour
National Neurosurgical Centre, Beaumont Hospital, Dublin, Ireland. jackhenry22@rcsi.ie.

BACKGROUND Up to 35% of aneurysmal subarachnoid haemorrhage (aSAH) cases may present as poor grade, defined as World Federation of Neurosurgical Societies (WFNS) grades IV and V. In this study, we evaluate functional outcomes and prognostic factors. METHODS This prospective study included all patients referred to a national, centralized neurosurgical service with a diagnosis of poor-grade aSAH between 01/01/2016 and 31/12/2019. Multivariable logistic regression models were used to estimate probability of poor functional outcomes, defined as a Glasgow Outcome Scale (GOS) of 1-3 at 3 months. RESULTS Two hundred fifty-seven patients were referred, of whom 116/257 (45.1%) underwent treatment of an aneurysm, with 97/116 (84%) treated within 48 h of referral. Median age was 62 years (IQR 51-69) with a female predominance (167/257, 65%). Untreated patients tended to be older; 123/141 (87%) had WFNS V, 60/141 (45%) unreactive pupils and 21/141 (16%) circulatory arrest. Of all referred patients, poor outcome occurred in 169/230 (73.5%). Unreactive pupils or circulatory arrest conferred a universally poor prognosis, with mortality in 55/56 (98%) and 19/19 (100%), respectively. The risk of a poor outcome was 14.1% (95% CI 4.5-23.6) higher in WFNS V compared with WFNS IV. Age was important in patients without circulatory arrest or unreactive pupils, with risk of a poor outcome increasing by 1.8% per year (95% CI 1-2.7). In patients undergoing aneurysm securement, 48/101 (47.5%) had a poor outcome, with age, rebleeding, vasospasm and cerebrospinal fluid (CSF) diversion being important prognosticators. The addition of serum markers did not add significant discrimination beyond the clinical presentation. CONCLUSIONS The overall outcomes of WFNS IV and V aSAH remain poor, mainly due to the devastating effects of the original haemorrhage. However, in patients selected for aneurysm securement, good outcomes can be achieved in more than half of patients. Age, pre-intervention rebleeding, vasospasm, and CSF diversion are important prognostic factors.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000783 Aneurysm Pathological outpouching or sac-like dilatation in the wall of any blood vessel (ARTERIES or VEINS) or the heart (HEART ANEURYSM). It indicates a thin and weakened area in the wall which may later rupture. Aneurysms are classified by location, etiology, or other characteristics. Saccular Aneurysm,Fusiform Aneurysm,Aneurysm, Fusiform,Aneurysms,Aneurysms, Fusiform,Fusiform Aneurysms
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013345 Subarachnoid Hemorrhage Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status. Hemorrhage, Subarachnoid,Perinatal Subarachnoid Hemorrhage,Subarachnoid Hemorrhage, Aneurysmal,Subarachnoid Hemorrhage, Spontaneous,SAH (Subarachnoid Hemorrhage),Subarachnoid Hemorrhage, Intracranial,Aneurysmal Subarachnoid Hemorrhage,Aneurysmal Subarachnoid Hemorrhages,Hemorrhage, Aneurysmal Subarachnoid,Hemorrhage, Intracranial Subarachnoid,Hemorrhage, Perinatal Subarachnoid,Hemorrhage, Spontaneous Subarachnoid,Hemorrhages, Aneurysmal Subarachnoid,Hemorrhages, Intracranial Subarachnoid,Hemorrhages, Perinatal Subarachnoid,Hemorrhages, Spontaneous Subarachnoid,Hemorrhages, Subarachnoid,Intracranial Subarachnoid Hemorrhage,Intracranial Subarachnoid Hemorrhages,Perinatal Subarachnoid Hemorrhages,SAHs (Subarachnoid Hemorrhage),Spontaneous Subarachnoid Hemorrhage,Spontaneous Subarachnoid Hemorrhages,Subarachnoid Hemorrhage, Perinatal,Subarachnoid Hemorrhages,Subarachnoid Hemorrhages, Aneurysmal,Subarachnoid Hemorrhages, Intracranial,Subarachnoid Hemorrhages, Perinatal,Subarachnoid Hemorrhages, Spontaneous
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D023261 Glasgow Outcome Scale A scale that assesses the outcome of serious craniocerebral injuries, based on the level of regained social functioning. Outcome Scale, Glasgow,Scale, Glasgow Outcome

Related Publications

Jack Henry, and Mohammed O Dablouk, and Dhruv Kapoor, and Stavros Koustais, and Paula Corr, and Deirdre Nolan, and Deirdre Coffey, and John Thornton, and Alan O'Hare, and Sarah Power, and Daniel Rawluk, and Mohsen Javadpour
April 2017, European journal of neurology,
Jack Henry, and Mohammed O Dablouk, and Dhruv Kapoor, and Stavros Koustais, and Paula Corr, and Deirdre Nolan, and Deirdre Coffey, and John Thornton, and Alan O'Hare, and Sarah Power, and Daniel Rawluk, and Mohsen Javadpour
April 2014, BMC neurology,
Jack Henry, and Mohammed O Dablouk, and Dhruv Kapoor, and Stavros Koustais, and Paula Corr, and Deirdre Nolan, and Deirdre Coffey, and John Thornton, and Alan O'Hare, and Sarah Power, and Daniel Rawluk, and Mohsen Javadpour
April 2000, British journal of neurosurgery,
Jack Henry, and Mohammed O Dablouk, and Dhruv Kapoor, and Stavros Koustais, and Paula Corr, and Deirdre Nolan, and Deirdre Coffey, and John Thornton, and Alan O'Hare, and Sarah Power, and Daniel Rawluk, and Mohsen Javadpour
April 2008, British journal of neurosurgery,
Jack Henry, and Mohammed O Dablouk, and Dhruv Kapoor, and Stavros Koustais, and Paula Corr, and Deirdre Nolan, and Deirdre Coffey, and John Thornton, and Alan O'Hare, and Sarah Power, and Daniel Rawluk, and Mohsen Javadpour
July 2020, Anaesthesia and intensive care,
Jack Henry, and Mohammed O Dablouk, and Dhruv Kapoor, and Stavros Koustais, and Paula Corr, and Deirdre Nolan, and Deirdre Coffey, and John Thornton, and Alan O'Hare, and Sarah Power, and Daniel Rawluk, and Mohsen Javadpour
November 2002, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Jack Henry, and Mohammed O Dablouk, and Dhruv Kapoor, and Stavros Koustais, and Paula Corr, and Deirdre Nolan, and Deirdre Coffey, and John Thornton, and Alan O'Hare, and Sarah Power, and Daniel Rawluk, and Mohsen Javadpour
March 1987, Neurological research,
Jack Henry, and Mohammed O Dablouk, and Dhruv Kapoor, and Stavros Koustais, and Paula Corr, and Deirdre Nolan, and Deirdre Coffey, and John Thornton, and Alan O'Hare, and Sarah Power, and Daniel Rawluk, and Mohsen Javadpour
November 2022, Acta neurologica Scandinavica,
Jack Henry, and Mohammed O Dablouk, and Dhruv Kapoor, and Stavros Koustais, and Paula Corr, and Deirdre Nolan, and Deirdre Coffey, and John Thornton, and Alan O'Hare, and Sarah Power, and Daniel Rawluk, and Mohsen Javadpour
January 2023, Frontiers in neurology,
Jack Henry, and Mohammed O Dablouk, and Dhruv Kapoor, and Stavros Koustais, and Paula Corr, and Deirdre Nolan, and Deirdre Coffey, and John Thornton, and Alan O'Hare, and Sarah Power, and Daniel Rawluk, and Mohsen Javadpour
April 2015, BMJ open,
Copied contents to your clipboard!